Document:

Exhibit
10.3

 

MyMD
Pharmaceuticals, INC.

2021
EQUITY INCENTIVE PLAN

 

The
MyMD Pharmaceuticals, Inc. 2021 Equity Incentive Plan (the “Plan”) was adopted by the Board of Directors of
MyMD Pharmaceuticals, Inc., a New Jersey corporation (the “Company”), effective as of April 16, 2021
(the “Effective Date”), subject to approval by the Company’s shareholders.

 

Article
1.

PURPOSE

 

The
purpose of the Plan is to attract and retain the services of key Employees, key Contractors, and Outside Directors of the Company and
its Subsidiaries and to provide such persons with a proprietary interest in the Company through the granting of Incentive Stock Options,
Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Awards, and Other Awards,
whether granted singly, or in combination, or in tandem, that will:

 

(a)
increase the interest of such persons in the Company’s welfare;

 

(b)
furnish an incentive to such persons to continue their services for the Company or its Subsidiaries; and

 

(c)
provide a means through which the Company may attract able persons as Employees, Contractors, and Outside Directors.

 

With
respect to Reporting Participants, the Plan and all transactions under the Plan are intended to comply with all applicable conditions
of Rule 16b-3 promulgated under the Exchange Act. To the extent any provision of the Plan or action by the Committee fails to so comply,
such provision or action shall be deemed null and void ab initio, to the extent permitted by law and deemed advisable by the Committee.

 

Article
2.

DEFINITIONS

 

For
the purpose of the Plan, unless the context requires otherwise, the following terms shall have the meanings indicated:

 

2.1
“Applicable Law” means all legal requirements relating to the administration of equity incentive plans and
the issuance and distribution of shares of Common Stock, if any, under applicable corporate laws, applicable securities laws, the rules
of any exchange or inter-dealer quotation system upon which the Company’s securities are listed or quoted, the rules of any foreign
jurisdiction applicable to Incentives granted to residents therein, and any other applicable law, rule or restriction.

 

2.2
“Award” means the grant of any Incentive Stock Option, Nonqualified Stock Option, Restricted Stock, SAR, Restricted
Stock Unit, Performance Award, or Other Award, whether granted singly or in combination or in tandem (each individually referred to herein
as an “Incentive”).

 

2.3
“Award Agreement” means a written agreement between a Participant and the Company which sets out the terms
of the grant of an Award.

 

    	 

    	 

    

 

2.4
“Award Period” means the period set forth in the Award Agreement during which one or more Incentives granted
under an Award may be exercised.

 

2.5
“Board” means the board of directors of the Company.

 

2.6
“Change in Control” means any of the following, except as otherwise provided herein: (a) any consolidation,
merger or share exchange of the Company in which the Company is not the continuing or surviving corporation or pursuant to which shares
of the Company’s Common Stock would be converted into cash, securities or other property, other than a consolidation, merger or
share exchange of the Company in which the holders of the Company’s Common Stock immediately prior to such transaction have the
same proportionate ownership of Common Stock of the surviving corporation immediately after such transaction; (b) any sale, lease, exchange
or other transfer (excluding transfer by way of pledge or hypothecation) in one transaction or a series of related transactions, of all
or substantially all of the assets of the Company; (c) the shareholders of the Company approve any plan or proposal for the liquidation
or dissolution of the Company; (d) the cessation of control (by virtue of their not constituting a majority of directors) of the Board
by the individuals (the “Continuing Directors”) who (x) at the date of this Plan were directors or (y) become
directors after the date of this Plan and whose election or nomination for election by the Company’s shareholders was approved
by a vote of at least two-thirds (2/3rds) of the directors then in office who were directors at the date of this Plan or whose
election or nomination for election was previously so approved; (e) the acquisition of beneficial ownership (within the meaning of Rule
13d-3 under the Exchange Act) of an aggregate of fifty percent (50%) or more of the voting power of the Company’s outstanding voting
securities by any person or group (as such term is used in Rule 13d-5 under the Exchange Act) who beneficially owned less than fifty
percent (50%) of the voting power of the Company’s outstanding voting securities on the date of this Plan; provided, however,
that notwithstanding the foregoing, an acquisition shall not constitute a Change in Control hereunder if the acquirer is (x) a trustee
or other fiduciary holding securities under an employee benefit plan of the Company and acting in such capacity, (y) a Subsidiary of
the Company or a corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions
as their ownership of voting securities of the Company or (z) any other person whose acquisition of shares of voting securities is approved
in advance by a majority of the Continuing Directors; or (f) in a Title 11 bankruptcy proceeding, the appointment of a trustee or the
conversion of a case involving the Company to a case under Chapter 7.

 

Notwithstanding
the foregoing provisions of this Section 2.66, if an Award issued under the Plan is subject to Section 409A of the Code, then
an event shall not constitute a Change in Control for purposes of such Award under the Plan unless such event also constitutes a change
in the Company’s ownership, its effective control or the ownership of a substantial portion of its assets within the meaning of
Section 409A of the Code.

 

2.7
“Claim” means any claim, liability, or obligation of any nature, arising out of or relating to this Plan or
an alleged breach of this Plan or an Award Agreement.

 

2.8
“Code” means the United States Internal Revenue Code of 1986, as amended.

 

2.9
“Committee” means the Compensation Committee of the Board or a subcommittee appointed by either the Compensation
Committee or the Board, or such other committee appointed or designated by the Board to administer the Plan in accordance with Article
3 of the Plan.

 

2.10
“Common Stock” means the common stock, no par value per share, which the Company is currently authorized to
issue or may in the future be authorized to issue, or any securities into which or for which the common stock of the Company may be converted
or exchanged, as the case may be, pursuant to the terms of this Plan.

 

    	-2-

    	 

    

 

2.11
“Company” means MyMD Pharmaceuticals, Inc., a New Jersey corporation, and any successor entity.

 

2.12
“Contractor” means any natural person, who is not an Employee, rendering bona fide services to the Company
or a Subsidiary, with compensation, as an independent contractor, provided that such services are not rendered in connection with the
offer or sale of securities in a capital raising transaction and do not directly or indirectly promote or maintain a market for the Company’s
securities.

 

2.13
“Corporation” means any entity that (a) is defined as a corporation under Section 7701 of the Code and (b)
is the Company or is in an unbroken chain of corporations (other than the Company) beginning with the Company, if each of the corporations
other than the last corporation in the unbroken chain owns stock possessing a majority of the total combined voting power of all classes
of stock in one of the other corporations in the chain. For purposes of clause (b) hereof, an entity shall be treated as a “corporation”
if it satisfies the definition of a corporation under Section 7701 of the Code.

 

2.14
“Date of Grant” means the effective date on which an Award is made to a Participant as set forth in the applicable
Award Agreement; provided, however, that solely for purposes of Section 16 of the Exchange Act and the rules and regulations promulgated
thereunder, the Date of Grant of an Award shall be the date of shareholder approval of the Plan if such date is later than the effective
date of such Award as set forth in the Award Agreement.

 

2.15
“Dividend Equivalent Right” means the right of the holder thereof to receive credits based on the cash dividends
that would have been paid on the shares of Common Stock specified in the Award if such shares were held by the Participant to whom the
Award is made.

 

2.16
“Employee” means a common law employee (as defined in accordance with the Regulations and Revenue Rulings then
applicable under Section 3401(c) of the Code) of the Company or any Subsidiary of the Company; provided, however,
in the case of individuals whose employment status, by virtue of their employer or residence, is not determined under Section 3401(c)
of the Code, “Employee” shall mean an individual treated as an employee for local payroll tax or employment purposes by the
applicable employer under Applicable Law for the relevant period.

 

2.17
“Exchange Act” means the United States Securities Exchange Act of 1934, as amended.

 

2.18
“Exercise Date” is the date (a) with respect to any Stock Option, that the Participant has delivered both the
Exercise Notice and consideration to the Company with a value equal to the total Option Price of the shares to be purchased (plus any
income and/or employment tax withholding or other tax payment due with respect to such Award); and (b) with respect to any SAR, that
the Participant has delivered both the Exercise Notice and consideration to the Company with a value equal to any income and/or employment
tax withholding or other tax payment due with respect to such SAR.

 

2.19
“Exercise Notice” is defined in Section 8.3(b) hereof.

 

2.20
“Fair Market Value” means, as of a particular date, (a) if the shares of Common Stock are listed on any established
national securities exchange, the closing sales price per share of Common Stock on the consolidated transaction reporting system for
the principal securities exchange for the Common Stock on that date (as determined by the Committee, in its discretion), or, if there
shall have been no such sale so reported on that date, on the last preceding date on which such a sale was so reported; (b) if the shares
of Common Stock are not so listed, but are quoted on an automated quotation system, the closing sales price per share of Common Stock
reported on the automated quotation system on that date, or, if there shall have been no such sale so reported on that date, on the last
preceding date on which such a sale was so reported; (c) if the Common Stock is not so listed or quoted, the mean between the closing
bid and asked price on that date, or, if there are no quotations available for such date, on the last preceding date on which such quotations
shall be available, as reported by the National Association of Securities Dealer, Inc.’s OTC Bulletin Board or the Pink OTC Markets,
Inc. (previously known as the National Quotation Bureau, Inc.); or (d) if none of the above is applicable, such amount as may be determined
by the Committee (acting on the advice of an Independent Third Party, should the Committee elect in its sole discretion to utilize an
Independent Third Party for this purpose), in good faith, to be the fair market value per share of Common Stock. The determination of
Fair Market Value shall, where applicable, be in compliance with Section 409A of the Code.

 

    	-3-

    	 

    

 

2.21
“Immediate Family Members” is defined in Section 15.8 hereof.

 

2.22
“Incentive” is defined in Section 2.2 hereof.

 

2.23
“Incentive Stock Option” means an incentive stock option within the meaning of Section 422 of the Code, granted
pursuant to this Plan.

 

2.24
“Independent Third Party” means an individual or entity independent of the Company having experience in providing
investment banking or similar appraisal or valuation services and with expertise generally in the valuation of securities or other property
for purposes of this Plan. The Committee may utilize one or more Independent Third Parties.

 

2.25
“Nonqualified Stock Option” means a nonqualified stock option, granted pursuant to this Plan, which is not
an Incentive Stock Option.

 

2.26
“Option Price” means the price which must be paid by a Participant upon exercise of a Stock Option to purchase
a share of Common Stock.

 

2.27
“Other Award” means an Award issued pursuant to Section 6.8 hereof.

 

2.28
“Outside Director” means a director of the Company who is not an Employee or a Contractor.

 

2.29
“Participant” means an Employee, Contractor, or an Outside Director to whom an Award is granted under this
Plan.

 

2.30
“Performance Award” means an Award hereunder of cash, shares of Common Stock, units or rights based upon, payable
in, or otherwise related to, Common Stock pursuant to Section 6.7 hereof.

 

2.31
“Performance Criteria” is defined in Section 6.9 hereof.

 

2.32
“Performance Goal” means any of the Performance Criteria set forth in Section 6.9 hereof.

 

2.33
“Plan” means this MyMD Pharmaceuticals, Inc. 2021 Equity Incentive Plan, as amended from time to time.

 

2.34
“Reporting Participant” means a Participant who is subject to the reporting requirements of Section 16 of the
Exchange Act.

 

    	-4-

    	 

    

 

2.35
“Restricted Stock” means shares of Common Stock issued or transferred to a Participant pursuant to Section
6.4 of this Plan which are subject to restrictions or limitations set forth in this Plan and in the related Award Agreement.

 

2.36
“Restricted Stock Units” means units awarded to Participants pursuant to Section 6.6 hereof, which are
convertible into Common Stock at such time as such units are no longer subject to restrictions as established by the Committee.

 

2.37
“Restriction Period” is defined in Section 6.4(b)(i) hereof.

 

2.38
“Retirement” shall have the meaning set forth in the Participant’s Award Agreement.

 

2.39
“SAR” or “Stock Appreciation Right” means the right to receive an amount, in cash
and/or Common Stock, equal to the excess of the Fair Market Value of a specified number of shares of Common Stock as of the date the
SAR is exercised (or, as provided in the Award Agreement, converted) over the SAR Price for such shares.

 

2.40
“SAR Price” means the exercise price or conversion price of each share of Common Stock covered by a SAR, determined
on the Date of Grant of the SAR.

 

2.41
“Spread” is defined in Section 12.4(b) hereof.

 

2.42
“Stock Option” means a Nonqualified Stock Option or an Incentive Stock Option.

 

2.43
“Subsidiary” means (a) any corporation in an unbroken chain of corporations beginning with the Company, if
each of the corporations other than the last corporation in the unbroken chain owns stock possessing a majority of the total combined
voting power of all classes of stock in one of the other corporations in the chain, (b) any limited partnership, if the Company or any
corporation described in item (a) above owns a majority of the general partnership interest and a majority of the limited partnership
interests entitled to vote on the removal and replacement of the general partner, and (c) any partnership or limited liability company,
if the partners or members thereof are composed only of the Company, any corporation listed in item (a) above or any limited partnership
listed in item (b) above. “Subsidiaries” means more than one of any such corporations, limited partnerships,
partnerships, or limited liability companies.

 

2.44
“Termination of Service” occurs when a Participant who is (a) an Employee of the Company or any Subsidiary
ceases to serve as an Employee of the Company and its Subsidiaries, for any reason; (b) an Outside Director of the Company or a Subsidiary
ceases to serve as a director of the Company and its Subsidiaries for any reason; or (c) a Contractor of the Company or a Subsidiary
ceases to serve as a Contractor of the Company and its Subsidiaries for any reason. Except as may be necessary or desirable to comply
with applicable federal or state law, a “Termination of Service” shall not be deemed to have occurred when a Participant
who is an Employee becomes an Outside Director or Contractor or vice versa. If, however, a Participant who is an Employee and who has
an Incentive Stock Option ceases to be an Employee but does not suffer a Termination of Service, and if that Participant does not exercise
the Incentive Stock Option within the time required under Section 422 of the Code upon ceasing to be an Employee, the Incentive Stock
Option shall thereafter become a Nonqualified Stock Option. Notwithstanding the foregoing provisions of this Section 2.444, in
the event an Award issued under the Plan is subject to Section 409A of the Code, then, in lieu of the foregoing definition and to the
extent necessary to comply with the requirements of Section 409A of the Code, the definition of “Termination of Service”
for purposes of such Award shall be the definition of “separation from service” provided for under Section 409A of the Code
and the regulations or other guidance issued thereunder.

 

    	-5-

    	 

    

 

2.45
“Total and Permanent Disability” means a Participant is qualified for long-term disability benefits under the
Company’s or Subsidiary’s disability plan or insurance policy; or, if no such plan or policy is then in existence or if the
Participant is not eligible to participate in such plan or policy, that the Participant, because of a physical or mental condition resulting
from bodily injury, disease, or mental disorder, is unable to perform his or her duties of employment for a period of six (6) continuous
months, as determined in good faith by the Committee, based upon medical reports or other evidence satisfactory to the Committee; provided
that, with respect to any Incentive Stock Option, Total and Permanent Disability shall have the meaning given it under the rules
governing Incentive Stock Options under the Code. Notwithstanding the foregoing provisions of this Section 2.45, in the event
an Award issued under the Plan is subject to Section 409A of the Code, then, in lieu of the foregoing definition and to the extent necessary
to comply with the requirements of Section 409A of the Code, the definition of “Total and Permanent Disability” for purposes
of such Award shall be the definition of “disability” provided for under Section 409A of the Code and the regulations or
other guidance issued thereunder.

 

Article
3.

ADMINISTRATION

 

Subject
to the terms of this Article 3, the Plan shall be administered by the Committee. The Committee shall consist of not fewer than
two persons. Any member of the Committee may be removed at any time, with or without cause, by resolution of the Board. Any vacancy occurring
in the membership of the Committee may be filled by appointment by the Board. At any time there is no Committee to administer the Plan,
any references in this Plan to the Committee shall be deemed to refer to the Board.

 

If
necessary to satisfy the requirements of Rule 16b-3 promulgated under the Exchange Act, membership on the Committee shall be limited
to those members of the Board who are “non-employee directors” as defined in Rule 16b-3 promulgated under the Exchange Act.
The Committee shall select one of its members to act as its Chairman. A majority of the Committee shall constitute a quorum, and the
act of a majority of the members of the Committee present at a meeting at which a quorum is present shall be the act of the Committee.

 

The
Committee shall determine and designate from time to time the eligible persons to whom Awards will be granted and shall set forth in
each related Award Agreement, where applicable, the Award Period, the Date of Grant, and such other terms, provisions, limitations, and
performance requirements, as are approved by the Committee, but not inconsistent with the Plan. The Committee shall determine whether
an Award shall include one type of Incentive or two or more Incentives granted in combination or two or more Incentives granted in tandem
(that is, a joint grant where exercise of one Incentive results in cancellation of all or a portion of the other Incentive). Although
the members of the Committee shall be eligible to receive Awards, all decisions with respect to any Award, and the terms and conditions
thereof, to be granted under the Plan to any member of the Committee shall be made solely and exclusively by the other members of the
Committee, or if such member is the only member of the Committee, by the Board.

 

The
Committee, in its discretion, shall (a) interpret the Plan and Award Agreements, (b) prescribe, amend, and rescind any rules and regulations
and sub-plans (including sub-plans for Awards made to Participants who are not resident in the United States), as necessary or appropriate
for the administration of the Plan, (c) establish performance goals for an Award and certify the extent of their achievement, and (d)
make such other determinations or certifications and take such other action as it deems necessary or advisable in the administration
of the Plan. Any interpretation, determination, or other action made or taken by the Committee shall be final, binding, and conclusive
on all interested parties. The Committee’s discretion set forth herein shall not be limited by any provision of the Plan, including
any provision which by its terms is applicable notwithstanding any other provision of the Plan to the contrary.

 

    	-6-

    	 

    

 

The
Committee may delegate to officers of the Company, pursuant to a written delegation, the authority to perform specified functions under
the Plan. Any actions taken by any officers of the Company pursuant to such written delegation of authority shall be deemed to have been
taken by the Committee. Notwithstanding the foregoing, to the extent necessary to satisfy the requirements of Rule 16b-3 promulgated
under the Exchange Act, any function relating to a Reporting Participant shall be performed solely by the Committee.

 

With
respect to restrictions in the Plan that are based on the requirements of Rule 16b-3 promulgated under the Exchange Act, Section 422
of the Code, the rules of any exchange or inter-dealer quotation system upon which the Company’s securities are listed or quoted,
or any other Applicable Law, to the extent that any such restrictions are no longer required by Applicable Law, the Committee shall have
the sole discretion and authority to grant Awards that are not subject to such mandated restrictions and/or to waive any such mandated
restrictions with respect to outstanding Awards.

 

Article
4.

ELIGIBILITY

 

Any
Employee (including an Employee who is also a director or an officer), Contractor or Outside Director of the Company whose judgment,
initiative, and efforts contributed or may be expected to contribute to the successful performance of the Company is eligible to participate
in the Plan; provided that only Employees of a Corporation shall be eligible to receive Incentive Stock Options. The Committee, upon
its own action, may grant, but shall not be required to grant, an Award to any Employee, Contractor or Outside Director. Awards may be
granted by the Committee at any time and from time to time to new Participants, or to then Participants, or to a greater or lesser number
of Participants, and may include or exclude previous Participants, as the Committee shall determine. Except as required by this Plan,
Awards need not contain similar provisions. The Committee’s determinations under the Plan (including without limitation determinations
of which Employees, Contractors or Outside Directors, if any, are to receive Awards, the form, amount and timing of such Awards, the
terms and provisions of such Awards and the agreements evidencing same) need not be uniform and may be made by it selectively among Participants
who receive, or are eligible to receive, Awards under the Plan.

 

Article
5.

SHARES
SUBJECT TO PLAN

 

5.1
Number Available for Awards. Subject to adjustment
as provided in Articles 11 and 12, the maximum number of shares of Common Stock that may be delivered pursuant to Awards granted
under the Plan is seven million, two hundred twenty-eight thousand, one hundred eighty-four (7,228,184) shares, of which one hundred
percent (100%) may be delivered pursuant to Incentive Stock Options. Shares to be issued may be made available from authorized but unissued
Common Stock, Common Stock held by the Company in its treasury, or Common Stock purchased by the Company on the open market or otherwise.
During the term of this Plan, the Company will at all times reserve and keep available the number of shares of Common Stock that shall
be sufficient to satisfy the requirements of this Plan.

 

5.2
Reuse of Shares. To the extent that any Award
under this Plan shall be forfeited, shall expire, or be canceled, in whole or in part, then the number of shares of Common Stock covered
by the Award so forfeited, expired, or canceled may again be awarded pursuant to the provisions of this Plan. Awards that may be satisfied
either by the issuance of shares of Common Stock or by cash or other consideration shall be counted against the maximum number of shares
of Common Stock that may be issued under this Plan only during the period that the Award is outstanding or to the extent the Award is
ultimately satisfied by the issuance of shares of Common Stock. Shares of Common Stock otherwise deliverable pursuant to an Award that
are withheld upon exercise or vesting of an Award for purposes of paying the exercise price or tax withholdings shall be treated as delivered
to the Participant and shall be counted against the maximum number of shares of Common Stock that may be issued under this Plan. Awards
will not reduce the number of shares of Common Stock that may be issued pursuant to this Plan if the settlement of the Award will not
require the issuance of shares of Common Stock, as, for example, a SAR that can be satisfied only by the payment of cash. Notwithstanding
any provisions of the Plan to the contrary, only shares forfeited back to the Company, or shares canceled on account of termination,
expiration or lapse of an Award, shall again be available for grant of Incentive Stock Options under the Plan, but shall not increase
the maximum number of shares described in Section 5.1 above as the maximum number of shares of Common Stock that may be delivered
pursuant to Incentive Stock Options.

 

    	-7-

    	 

    

 

Article
6.

GRANT
OF AWARDS

 

6.1
In General.

 

(a)
The grant of an Award shall be authorized by the Committee and shall be evidenced by an Award Agreement setting forth the Incentive or
Incentives being granted, the total number of shares of Common Stock subject to the Incentive(s), the Option Price (if applicable), the
Award Period, the Date of Grant, and such other terms, provisions, limitations, and performance objectives, as are approved by the Committee,
but (i) not inconsistent with the Plan and (ii) to the extent an Award issued under the Plan is subject to Section 409A of the Code,
in compliance with the applicable requirements of Section 409A of the Code and the regulations or other guidance issued thereunder. The
Company shall execute an Award Agreement with a Participant after the Committee approves the issuance of an Award. Any Award granted
pursuant to this Plan must be granted within ten (10) years of the date of adoption of this Plan by the Board. The Plan shall be submitted
to the Company’s shareholders for approval; however, the Committee may grant Awards under the Plan prior to the time of shareholder
approval. Any such Award granted prior to such shareholder approval shall be made subject to such shareholder approval. The grant of
an Award to a Participant shall not be deemed either to entitle the Participant to, or to disqualify the Participant from, receipt of
any other Award under the Plan.

 

(b)
If the Committee establishes a purchase price for an Award, the Participant must accept such Award within a period of thirty (30) days
(or such shorter period as the Committee may specify) after the Date of Grant by executing the applicable Award Agreement and paying
such purchase price.

 

(c)
Any Award under this Plan that is settled in whole or in part in cash on a deferred basis may provide for interest equivalents to be
credited with respect to such cash payment. Interest equivalents may be compounded and shall be paid upon such terms and conditions as
may be specified by the grant.

 

6.2
Option Price. The Option Price for any share
of Common Stock which may be purchased under a Nonqualified Stock Option for any share of Common Stock must be equal to or greater than
the Fair Market Value of the share on the Date of Grant. The Option Price for any share of Common Stock which may be purchased under
an Incentive Stock Option must be at least equal to the Fair Market Value of the share on the Date of Grant; if an Incentive Stock Option
is granted to an Employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than ten
percent (10%) of the combined voting power of all classes of stock of the Company (or any parent or Subsidiary), the Option Price shall
be at least one hundred ten percent (110%) of the Fair Market Value of the Common Stock on the Date of Grant. No dividends or Dividend
Equivalent Rights may be paid or granted with respect to any Stock Option granted hereunder.

 

    	-8-

    	 

    

 

6.3
Maximum ISO Grants. The Committee may not grant
Incentive Stock Options under the Plan to any Employee which would permit the aggregate Fair Market Value (determined on the Date of
Grant) of the Common Stock with respect to which Incentive Stock Options (under this and any other plan of the Company and its Subsidiaries)
are exercisable for the first time by such Employee during any calendar year to exceed $100,000. To the extent any Stock Option granted
under this Plan which is designated as an Incentive Stock Option exceeds this limit or otherwise fails to qualify as an Incentive Stock
Option, such Stock Option (or any such portion thereof) shall be a Nonqualified Stock Option. In such case, the Committee shall designate
which stock will be treated as Incentive Stock Option stock by causing the issuance of a separate stock certificate and identifying such
stock as Incentive Stock Option stock on the Company’s stock transfer records.

 

6.4
Restricted Stock. If Restricted Stock is granted
to or received by a Participant under an Award (including a Stock Option), the Committee shall set forth in the related Award Agreement:
(a) the number of shares of Common Stock awarded, (b) the price, if any, to be paid by the Participant for such Restricted Stock and
the method of payment of the price, (c) the time or times within which such Award may be subject to forfeiture, (d) specified Performance
Goals of the Company, a Subsidiary, any division thereof or any group of Employees of the Company, or other criteria, which the Committee
determines must be met in order to remove any restrictions (including vesting) on such Award, and (e) all other terms, limitations, restrictions,
and conditions of the Restricted Stock, which shall be consistent with this Plan, to the extent applicable and, to the extent Restricted
Stock granted under the Plan is subject to Section 409A of the Code, in compliance with the applicable requirements of Section 409A of
the Code and the regulations or other guidance issued thereunder. The provisions of Restricted Stock need not be the same with respect
to each Participant.

 

(a)
Legend on Shares. The Company shall electronically register the Restricted Stock awarded to a Participant in the name of such
Participant, which shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted
Stock, substantially as provided in Section 15.10 of the Plan. No stock certificate or certificates shall be issued with respect
to such shares of Common Stock, unless, following the expiration of the Restriction Period (as defined in Section 6.4(b)(i)) without
forfeiture in respect of such shares of Common Stock, the Participant requests delivery of the certificate or certificates by submitting
a written request to the Committee (or such party designated by the Company) requesting delivery of the certificates. The Company shall
deliver the certificates requested by the Participant to the Participant as soon as administratively practicable following the Company’s
receipt of such request.

 

(b)
Restrictions and Conditions. Shares of Restricted Stock shall be subject to the following restrictions and conditions:

 

(i)
Subject to the other provisions of this Plan and the terms of the particular Award Agreements, during such period as may be determined
by the Committee commencing on the Date of Grant or the date of exercise of an Award (the “Restriction Period”),
the Participant shall not be permitted to sell, transfer, pledge or assign shares of Restricted Stock. Except for these limitations and
the limitations set forth in Section 7.2 below, the Committee may in its sole discretion, remove any or all of the restrictions
on such Restricted Stock whenever it may determine that, by reason of changes in Applicable Laws or other changes in circumstances arising
after the date of the Award, such action is appropriate.

 

    	-9-

    	 

    

 

(ii)
Except as provided in sub-paragraph (i) above or in the applicable Award Agreement, the Participant shall have, with respect to his or
her Restricted Stock, all of the rights of a shareholder of the Company, including the right to vote the shares, and the right to receive
any dividends thereon, provided that (A) any dividends with respect to such an Award may be withheld by the Company for the Participant’s
account until such Award is vested, subject to such terms as determined by the Committee, and (B) any dividends so withheld by the Company
and attributable to any particular Award shall be distributed to such Participant in cash or, at the discretion of the Committee, in
shares of Common Stock having a Fair Market Value equal to the amount of such dividends, if applicable, upon vesting of the Award, and
if such Award is forfeited, the Participant shall have no right to such dividends. Certificates for shares of Common Stock free of restriction
under this Plan shall be delivered to the Participant promptly after, and only after, the Restriction Period shall expire without forfeiture
in respect of such shares of Common Stock or after any other restrictions imposed on such shares of Common Stock by the applicable Award
Agreement or other agreement have expired. Certificates for the shares of Common Stock forfeited under the provisions of the Plan and
the applicable Award Agreement shall be promptly returned to the Company by the forfeiting Participant. Each Award Agreement shall require
that each Participant, in connection with the issuance of a certificate for Restricted Stock, shall endorse such certificate in blank
or execute a stock power in form satisfactory to the Company in blank and deliver such certificate and executed stock power to the Company.

 

(iii)
The Restriction Period of Restricted Stock shall commence on the Date of Grant or the date of exercise of an Award, as specified in the
Award Agreement, and, subject to Article 12 of the Plan, unless otherwise established by the Committee in the Award Agreement
setting forth the terms of the Restricted Stock, shall expire upon satisfaction of the conditions set forth in the Award Agreement; such
conditions may provide for vesting based on length of continuous service or such Performance Goals, as may be determined by the Committee
in its sole discretion.

 

(iv)
Except as otherwise provided in the particular Award Agreement, upon Termination of Service for any reason during the Restriction Period,
the nonvested shares of Restricted Stock shall be forfeited by the Participant. In the event a Participant has paid any consideration
to the Company for such forfeited Restricted Stock, the Committee shall specify in the Award Agreement that either (1) the Company shall
be obligated to, or (2) the Company may, in its sole discretion, elect to, pay to the Participant, as soon as practicable after the event
causing forfeiture, in cash, an amount equal to the lesser of the total consideration paid by the Participant for such forfeited shares
or the Fair Market Value of such forfeited shares as of the date of Termination of Service, as the Committee, in its sole discretion
shall select. Upon any forfeiture, all rights of a Participant with respect to the forfeited shares of the Restricted Stock shall cease
and terminate, without any further obligation on the part of the Company.

 

6.5
SARs. The Committee may grant SARs to any Participant,
either as a separate Award or in connection with a Stock Option. SARs shall be subject to such terms and conditions as the Committee
shall impose, provided that such terms and conditions are (a) not inconsistent with the Plan, and (b) to the extent a SAR issued under
the Plan is subject to Section 409A of the Code, in compliance with the applicable requirements of Section 409A of the Code and the regulations
or other guidance issued thereunder. The grant of the SAR may provide that the holder may be paid for the value of the SAR either in
cash or in shares of Common Stock, or a combination thereof. In the event of the exercise of a SAR payable in shares of Common Stock,
the holder of the SAR shall receive that number of whole shares of Common Stock having an aggregate Fair Market Value on the date of
exercise equal to the value obtained by multiplying (a) the difference between the Fair Market Value of a share of Common Stock on the
date of exercise over the SAR Price as set forth in such SAR (or other value specified in the agreement granting the SAR), by (b) the
number of shares of Common Stock as to which the SAR is exercised, with a cash settlement to be made for any fractional shares of Common
Stock. The SAR Price for any share of Common Stock subject to a SAR may be equal to or greater than the Fair Market Value of the share
on the Date of Grant. The Committee, in its sole discretion, may place a ceiling on the amount payable upon exercise of a SAR, but any
such limitation shall be specified at the time that the SAR is granted. No dividends or Dividend Equivalent Rights may be paid or granted
with respect to any SARs granted hereunder.

 

    	-10-

    	 

    

 

6.6
Restricted Stock Units. Restricted Stock Units
may be awarded or sold to any Participant under such terms and conditions as shall be established by the Committee, provided, however,
that such terms and conditions are (a) not inconsistent with the Plan, and (b) to the extent a Restricted Stock Unit issued under the
Plan is subject to Section 409A of the Code, in compliance with the applicable requirements of Section 409A of the Code and the regulations
or other guidance issued thereunder. Restricted Stock Units shall be subject to such restrictions as the Committee determines, including,
without limitation, (a) a prohibition against sale, assignment, transfer, pledge, hypothecation or other encumbrance for a specified
period; or (b) a requirement that the holder forfeit (or in the case of shares of Common Stock or units sold to the Participant, resell
to the Company at cost) such shares or units in the event of Termination of Service during the period of restriction.

 

6.7
Performance Awards.

 

(a) The
Committee may grant Performance Awards to one or more Participants. The terms and conditions of Performance Awards shall be specified
at the time of the grant and may include provisions establishing the performance period, the Performance Goals to be achieved during
a performance period, and the maximum or minimum settlement values, provided that such terms and conditions are (i) not inconsistent
with the Plan and (ii) to the extent a Performance Award issued under the Plan is subject to Section 409A of the Code, in compliance
with the applicable requirements of Section 409A of the Code and the regulations or other guidance issued thereunder. If the Performance
Award is to be in shares of Common Stock, the Performance Awards may provide for the issuance of the shares of Common Stock at the time
of the grant of the Performance Award or at the time of the certification by the Committee that the Performance Goals for the performance
period have been met; provided, however, if shares of Common Stock are issued at the time of the grant of the Performance
Award and if, at the end of the performance period, the Performance Goals are not certified by the Committee to have been fully satisfied,
then, notwithstanding any other provisions of this Plan to the contrary, the Common Stock shall be forfeited in accordance with the terms
of the grant to the extent the Committee determines that the Performance Goals were not met. The forfeiture of shares of Common Stock
issued at the time of the grant of the Performance Award due to failure to achieve the established Performance Goals shall be separate
from and in addition to any other restrictions provided for in this Plan that may be applicable to such shares of Common Stock. Each
Performance Award granted to one or more Participants shall have its own terms and conditions.

 

If
the Committee determines, in its sole discretion, that the established performance measures or objectives are no longer suitable because
of a change in the Company’s business, operations, corporate structure, or for other reasons that the Committee deemed satisfactory,
the Committee may modify the performance measures or objectives and/or the performance period.

 

    	-11-

    	 

    

 

(b) Performance Awards may be valued by reference to the Fair Market Value of a share of Common Stock or according to any formula or
method deemed appropriate by the Committee, in its sole discretion, including, but not limited to, achievement of Performance Goals
or other specific financial, production, sales or cost performance objectives that the Committee believes to be relevant to the
Company’s business and/or remaining in the employ of the Company or a Subsidiary for a specified period of time. Performance
Awards may be paid in cash, shares of Common Stock, or other consideration, or any combination thereof. If payable in shares of
Common Stock, the consideration for the issuance of such shares may be the achievement of the performance objective established at
the time of the grant of the Performance Award. Performance Awards may be payable in a single payment or in installments and may be
payable at a specified date or dates or upon attaining the performance objective. The extent to which any applicable performance
objective has been achieved shall be conclusively determined by the Committee.

 

6.8
Other Awards. The Committee may grant to any
Participant other forms of Awards, based upon, payable in, or otherwise related to, in whole or in part, shares of Common Stock, if the
Committee determines that such other form of Award is consistent with the purpose and restrictions of this Plan. The terms and conditions
of such other form of Award shall be specified by the grant. Such Other Awards may be granted for no cash consideration, for such minimum
consideration as may be required by Applicable Law, or for such other consideration as may be specified by the grant.

 

6.9
Performance Goals. Awards of Restricted Stock,
Restricted Stock Units, Performance Award and Other Awards (whether relating to cash or shares of Common Stock) under the Plan may be
made subject to the attainment of Performance Goals relating to one or more business criteria which may consist of one or more or any
combination of the following criteria: cash (cash flow, cash generation or other cash measures); cost; revenues; sales; ratio of debt
to debt plus equity; net borrowing, credit quality or debt ratings; profit before tax; economic profit; earnings before interest and
taxes; earnings before interest, taxes, depreciation and amortization; gross margin; earnings per share (whether on a pre-tax, after-tax,
operational or other basis); operating earnings; capital expenditures; improvements in capital structure; expenses (expense management,
expense ratio, expense efficiency ratios, expense levels or other expense measures); economic value added; ratio of operating earnings
to capital spending or any other operating ratios; free cash flow; profit (net profit, gross profit, operating profit, economic profit,
profit margin or other corporate profit measures); net income (before or after taxes, operating income or other income measures); net
sales; net asset value per share; business expansion or consolidation (the accomplishment of mergers, acquisitions, dispositions, public
offerings or similar extraordinary business transactions); sales growth; price of the Company’s Common Stock; return measures (including,
without limitation, return on assets, capital, equity, investments or sales, and cash flow return on assets, capital, equity, or sales);
market share; inventory levels, inventory management, inventory turn or shrinkage; stock price or performance; internal rate of return
or increase in net present value; working capital targets relating to inventory and/or accounts receivable; service or product delivery
or quality; customer satisfaction; employee retention; safety standards; productivity measures; cost reduction measures; strategic plan
development and implementation; or total return to shareholders (“Performance Criteria”). Any Performance Criteria
may be used to measure the performance of the Company as a whole or any business unit of the Company and may be measured relative to
a peer group or index. Any Performance Criteria may include or exclude (a) events that are of an unusual nature or indicate infrequency
of occurrence, (b) gains or losses on the disposition of a business, (c) changes in tax or accounting regulations or laws, (d) the effect
of a merger or acquisition, as identified in the Company’s quarterly and annual earnings releases, or (e) other similar occurrences.
In all other respects, Performance Criteria shall be calculated in accordance with the Company’s financial statements, under generally
accepted accounting principles, or under a methodology established by the Committee prior to the issuance of an Award which is consistently
applied and identified in the audited financial statements, including footnotes, or the Compensation Discussion and Analysis section
of the Company’s annual report.

 

    	-12-

    	 

    

 

6.10
Tandem Awards. The Committee may grant two or
more Incentives in one Award in the form of a “tandem Award,” so that the right of the Participant to exercise one Incentive
shall be canceled if, and to the extent, the other Incentive is exercised. For example, if a Stock Option and a SAR are issued in a tandem
Award, and the Participant exercises the SAR with respect to one hundred (100) shares of Common Stock, the right of the Participant to
exercise the related Stock Option shall be canceled to the extent of one hundred (100) shares of Common Stock.

 

6.11
No Repricing of Stock Options or SARs. The Committee
may not, without the approval of the Company’s shareholders, “reprice” any Stock Option or SAR. For purposes of this
Section 6.11, “reprice” means any of the following or any other action that has the same effect: (a) amending a Stock
Option or SAR to reduce its exercise price or SAR price, (b) canceling a Stock Option or SAR at a time when its exercise price or SAR
price exceeds the Fair Market Value of a share of Common Stock in exchange for cash or a Stock Option, SAR, award of Restricted Stock
or other equity award with an exercise price or SAR price less than the exercise price or SAR price of the original Stock Option or SAR,
or (c) taking any other action that is treated as a repricing under generally accepted accounting principles, provided that nothing in
this Section 6.11 shall prevent the Committee from making adjustments pursuant to Article 11, from exchanging or cancelling
Incentives pursuant to Article 12, or substituting Incentives in accordance with Article 14.

 

6.12
Recoupment for Restatements. Notwithstanding
any other language in this Plan to the contrary, the Company may recoup all or any portion of any shares or cash paid to a Participant
in connection with an Award, in the event of a restatement of the Company’s financial statements as set forth in the Company’s
clawback policy, if any, approved by the Company’s Board from time to time.

 

Article
7.

AWARD
PERIOD; VESTING

 

7.1
Award Period. Subject to the other provisions
of this Plan, the Committee may, in its discretion, provide that an Incentive may not be exercised in whole or in part for any period
or periods of time or beyond any date specified in the Award Agreement. Except as provided in the Award Agreement, an Incentive may be
exercised in whole or in part at any time during its term. The Award Period for an Incentive shall be reduced or terminated upon Termination
of Service. No Incentive granted under the Plan may be exercised at any time after the end of its Award Period. No portion of any Incentive
may be exercised after the expiration of ten (10) years from its Date of Grant. However, if an Employee owns or is deemed to own (by
reason of the attribution rules of Section 424(d) of the Code) more than ten percent (10%) of the combined voting power of all classes
of stock of the Company (or any parent or Subsidiary) and an Incentive Stock Option is granted to such Employee, the term of such Incentive
Stock Option (to the extent required by the Code at the time of grant) shall be no more than five (5) years from the Date of Grant.

 

7.2
Vesting. The Committee, in its sole discretion,
may determine at the time of grant or any time thereafter that an Incentive will be immediately vested in whole or in part, or that all
or any portion may not be vested until a date, or dates, subsequent to its Date of Grant, or until the occurrence of one or more specified
events, subject in any case to the terms of the Plan. If the Committee imposes conditions upon vesting, then, subsequent to the Date
of Grant, the Committee may, in its sole discretion, accelerate the date on which all or any portion of the Incentive may be vested or
waive the Restriction Period applicable to an Incentive at any time.

 

    	-13-

    	 

    

 

Article
8.

EXERCISE
OR CONVERSION OF INCENTIVE

 

8.1
In General. A vested Incentive may be exercised
or converted, during its Award Period, subject to limitations and restrictions set forth in the Award Agreement.

 

8.2
Securities Law and Exchange Restrictions. In
no event may an Incentive be exercised or shares of Common Stock issued pursuant to an Award if a necessary listing or quotation of the
shares of Common Stock on a stock exchange or inter-dealer quotation system or any registration under state or federal securities laws
required under the circumstances has not been accomplished.

 

8.3
Exercise of Stock Option.

 

(a)
In General. If a Stock Option is exercisable prior to the time it is vested, the Common Stock obtained on the exercise of the
Stock Option shall be Restricted Stock which is subject to the applicable provisions of the Plan and the Award Agreement. If the Committee
imposes conditions upon exercise, then subsequent to the Date of Grant, the Committee may, in its sole discretion, accelerate the date
on which all or any portion of the Stock Option may be exercised. No Stock Option may be exercised for a fractional share of Common Stock.
The granting of a Stock Option shall impose no obligation upon the Participant to exercise that Stock Option.

 

(b)
Notice and Payment. Subject to such administrative regulations as the Committee may from time to time adopt, a Stock Option may
be exercised by the delivery of written notice to the Committee setting forth the number of shares of Common Stock with respect to which
the Stock Option is to be exercised (the “Exercise Notice”) and the Exercise Date. The consideration due with
respect to the exercise of a Stock Option shall be payable as provided in the Award Agreement, which may provide for payment in any one
or more of the following ways: (i) cash or check, bank draft, or money order payable to the order of the Company, (ii) Common Stock (including
Restricted Stock) owned by the Participant on the Exercise Date, valued at its Fair Market Value on the Exercise Date, and which the
Participant has not acquired from the Company within six (6) months prior to the Exercise Date, (iii) by delivery (including by FAX or
electronic transmission) to the Company or its designated agent of an executed irrevocable option exercise form (or, to the extent permitted
by the Company, exercise instructions, which may be communicated in writing, telephonically, or electronically) together with irrevocable
instructions from the Participant to a broker or dealer, reasonably acceptable to the Company, to sell certain of the shares of Common
Stock purchased upon exercise of the Stock Option or to pledge such shares as collateral for a loan and promptly deliver to the Company
the amount of sale or loan proceeds necessary to pay such purchase price, (iv) by requesting the Company to withhold the number of shares
otherwise deliverable upon exercise of the Stock Option by the number of shares of Common Stock having an aggregate Fair Market Value
equal to the aggregate Option Price at the time of exercise (i.e., a cashless net exercise), and/or (v) in any other form of valid
consideration that is acceptable to the Committee in its sole discretion. In the event that shares of Restricted Stock are tendered as
consideration for the exercise of a Stock Option, a number of shares of Common Stock issued upon the exercise of the Stock Option equal
to the number of shares of Restricted Stock used as consideration therefor shall be subject to the same restrictions and provisions as
the Restricted Stock so tendered. If the Participant fails to deliver the consideration described in this Section 8.3(b) within
three (3) business days of the date of the Exercise Notice, then the Exercise Notice shall be null and void and the Company will have
no obligation to deliver any shares of Common Stock to the Participant in connection with such Exercise Notice.

 

    	-14-

    	 

    

 

(c)
Issuance of Certificate. Except as otherwise provided in Section 6.4 hereof (with respect to shares of Restricted Stock)
or in the applicable Award Agreement, upon payment of all amounts due from the Participant, the Company shall cause the Common Stock
then being purchased to be registered in the Participant’s name (or the person exercising the Participant’s Stock Option
in the event of his or her death), but shall not issue certificates for the Common Stock unless the Participant or such other person
requests delivery of the certificates for the Common Stock, in writing in accordance with the procedures established by the Committee.
The Company shall deliver certificates to the Participant (or the person exercising the Participant’s Stock Option in the event
of his or her death) as soon as administratively practicable following the Company’s receipt of a written request from the Participant
or such other person for delivery of the certificates. Notwithstanding the forgoing, if the Participant has exercised an Incentive Stock
Option, the Company may at its option retain physical possession of the certificate evidencing the shares acquired upon exercise until
the expiration of the holding periods described in Section 422(a)(1) of the Code. Any obligation of the Company to deliver shares of
Common Stock shall, however, be subject to the condition that, if at any time the Committee shall determine in its discretion that the
listing, registration, or qualification of the Stock Option or the Common Stock upon any securities exchange or inter-dealer quotation
system or under any state or federal law, or the consent or approval of any governmental regulatory body, is necessary as a condition
of, or in connection with, the Stock Option or the issuance or purchase of shares of Common Stock thereunder, the Stock Option may not
be exercised in whole or in part unless such listing, registration, qualification, consent, or approval shall have been effected or obtained
free of any conditions not reasonably acceptable to the Committee.

 

(d)
Failure to Pay. Except as may otherwise be provided in an Award Agreement, if the Participant fails to pay for any of the Common
Stock specified in such notice or fails to accept delivery thereof, that portion of the Participant’s Stock Option and right to
purchase such Common Stock may be forfeited by the Participant.

 

8.4
SARs. Subject to the conditions of this Section
8.4 and such administrative regulations as the Committee may from time to time adopt, a SAR may be exercised by the delivery (including
by FAX) of an Exercise Notice to the Committee setting forth the number of shares of Common Stock with respect to which the SAR is to
be exercised and the Exercise Date, which shall be at least three (3) days after giving such notice unless an earlier time shall have
been mutually agreed upon. Subject to the terms of the Award Agreement and only if permissible under Section 409A of the Code and the
regulations or other guidance issued thereunder (or, if not so permissible, at such time as permitted by Section 409A of the Code and
the regulations or other guidance issued thereunder), the Participant shall receive from the Company in exchange therefor in the discretion
of the Committee, and subject to the terms of the Award Agreement:

 

(a)
cash in an amount equal to the excess (if any) of the Fair Market Value (as of the Exercise Date, or if provided in the Award Agreement,
conversion, of the SAR) per share of Common Stock over the SAR Price per share specified in such SAR, multiplied by the total number
of shares of Common Stock of the SAR being surrendered;

 

(b)
that number of shares of Common Stock having an aggregate Fair Market Value (as of the Exercise Date, or if provided in the Award Agreement,
conversion, of the SAR) equal to the amount of cash otherwise payable to the Participant, with a cash settlement to be made for any fractional
share interests; or

 

(c)
the Company may settle such obligation in part with shares of Common Stock and in part with cash.

 

    	-15-

    	 

    

 

The
distribution of any cash or Common Stock pursuant to the foregoing sentence shall be made at such time as set forth in the Award Agreement.

 

8.5
Disqualifying Disposition of Incentive Stock Option.
If shares of Common Stock acquired upon exercise of an Incentive Stock Option are disposed of by a Participant prior to the expiration
of either two (2) years from the Date of Grant of such Stock Option or one (1) year from the transfer of shares of Common Stock to the
Participant pursuant to the exercise of such Stock Option, or in any other disqualifying disposition within the meaning of Section 422
of the Code, such Participant shall notify the Company in writing of the date and terms of such disposition. A disqualifying disposition
by a Participant shall not affect the status of any other Stock Option granted under the Plan as an Incentive Stock Option within the
meaning of Section 422 of the Code.

 

Article
9.

AMENDMENT
OR DISCONTINUANCE

 

Subject
to the limitations set forth in this Article 9, the Board may at any time and from time to time, without the consent of the Participants,
alter, amend, revise, suspend, or discontinue the Plan in whole or in part; provided, however, that no amendment for which shareholder
approval is required either (a) by any securities exchange or inter-dealer quotation system on which the Common Stock is listed or traded
or (b) in order for the Plan and Incentives awarded under the Plan to continue to comply with Sections 421 and 422 of the Code, including
any successors to such Sections, or other Applicable Law, shall be effective unless such amendment shall be approved by the requisite
vote of the shareholders of the Company entitled to vote thereon. Any such amendment shall, to the extent deemed necessary or advisable
by the Committee, be applicable to any outstanding Incentives theretofore granted under the Plan, notwithstanding any contrary provisions
contained in any Award Agreement. In the event of any such amendment to the Plan, the holder of any Incentive outstanding under the Plan
shall, upon request of the Committee and as a condition to the exercisability thereof, execute a conforming amendment in the form prescribed
by the Committee to any Award Agreement relating thereto. Notwithstanding anything contained in this Plan to the contrary, unless required
by law, no action contemplated or permitted by this Article 9 shall adversely affect any rights of Participants or obligations
of the Company to Participants with respect to any Incentive theretofore granted under the Plan without the consent of the affected Participant.

 

Article
10.

TERM

 

The
Plan shall be effective from the date that this Plan is adopted by the Board. Unless sooner terminated by action of the Board, the Plan
will terminate on the tenth anniversary of the Effective Date, but Incentives granted before that date will continue to be effective
in accordance with their terms and conditions.

 

    	-16-

    	 

    

 

Article
11.

CAPITAL ADJUSTMENTS

 

In
the event that any dividend or other distribution (whether in the form of cash, Common Stock, other securities, or other property), recapitalization,
stock split, reverse stock split, rights offering, reorganization, merger, consolidation, split-up, spin-off, split-off, combination,
subdivision, repurchase, or exchange of Common Stock or other securities of the Company, issuance of warrants or other rights to purchase
Common Stock or other securities of the Company, or other similar corporate transaction or event affects the fair value of an Award,
then the Committee shall adjust any or all of the following so that the fair value of the Award immediately after the transaction or
event is equal to the fair value of the Award immediately prior to the transaction or event (a) the number of shares and type of Common
Stock (or the securities or property) which thereafter may be made the subject of Awards, (b) the number of shares and type of Common
Stock (or other securities or property) subject to outstanding Awards, (c) the number of shares and type of Common Stock (or other securities
or property) specified as the annual per-participant limitation under Section 5.1 of the Plan, (d) the Option Price of each outstanding
Award, (e) the amount, if any, the Company pays for forfeited shares of Common Stock in accordance with Section 6.4, and (f) the
number of or SAR Price of shares of Common Stock then subject to outstanding SARs previously granted and unexercised under the Plan,
to the end that the same proportion of the Company’s issued and outstanding shares of Common Stock in each instance shall remain
subject to exercise at the same aggregate SAR Price; provided, however, that the number of shares of Common Stock (or other securities
or property) subject to any Award shall always be a whole number. Notwithstanding the foregoing, no such adjustment shall be made or
authorized to the extent that such adjustment would cause the Plan or any Stock Option to violate Section 422 of the Code or Section
409A of the Code. Such adjustments shall be made in accordance with the rules of any securities exchange, stock market, or stock quotation
system to which the Company is subject.

 

Upon
the occurrence of any such adjustment, the Company shall provide notice to each affected Participant of its computation of such adjustment
which shall be conclusive and shall be binding upon each such Participant.

 

Article
12.

RECAPITALIZATION, MERGER AND CONSOLIDATION

 

12.1
No Effect on Company’s Authority. The existence
of this Plan and Incentives granted hereunder shall not affect in any way the right or power of the Company or its shareholders to make
or authorize any or all adjustments, recapitalizations, reorganizations, or other changes in the Company’s capital structure and
its business, or any Change in Control, or any merger or consolidation of the Company, or any issuance of bonds, debentures, preferred
or preference stocks ranking prior to or otherwise affecting the Common Stock or the rights thereof (or any rights, options, or warrants
to purchase same), or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business,
or any other corporate act or proceeding, whether of a similar character or otherwise.

 

12.2
Conversion of Incentives Where Company Survives.
Subject to any required action by the shareholders and except as otherwise provided by Section 12.4 hereof or as may be required
to comply with Section 409A of the Code and the regulations or other guidance issued thereunder, if the Company shall be the surviving
or resulting corporation in any merger, consolidation or share exchange, any Incentive granted hereunder shall pertain to and apply to
the securities or rights (including cash, property, or assets) to which a holder of the number of shares of Common Stock subject to the
Incentive would have been entitled.

 

12.3
Exchange or Cancellation of Incentives Where Company
Does Not Survive. Except as otherwise provided by Section 12.4 hereof or as may be required to comply with Section 409A of
the Code and the regulations or other guidance issued thereunder, in the event of any merger, consolidation or share exchange pursuant
to which the Company is not the surviving or resulting corporation, there shall be substituted for each share of Common Stock subject
to the unexercised portions of outstanding Incentives, that number of shares of each class of stock or other securities or that amount
of cash, property, or assets of the surviving, resulting or consolidated company which were distributed or distributable to the shareholders
of the Company in respect to each share of Common Stock held by them, such outstanding Incentives to be thereafter exercisable for such
stock, securities, cash, or property in accordance with their terms.

 

    	-17-

    	 

    

 

12.4
Cancellation of Incentives. Notwithstanding the
provisions of Sections 12.2 and 12.3 hereof, and except as may be required to comply with Section 409A of the Code and the regulations
or other guidance issued thereunder, all Incentives granted hereunder may be canceled by the Company, in its sole discretion, as of the
effective date of any Change in Control, merger, consolidation or share exchange, or any issuance of bonds, debentures, preferred or
preference stocks ranking prior to or otherwise affecting the Common Stock or the rights thereof (or any rights, options, or warrants
to purchase same), or of any proposed sale of all or substantially all of the assets of the Company, or of any dissolution or liquidation
of the Company, by either:

 

(a)
giving notice to each holder thereof or his personal representative of its intention to cancel those Incentives for which the issuance
of shares of Common Stock involved payment by the Participant for such shares, and permitting the purchase during the thirty (30) day
period next preceding such effective date of any or all of the shares of Common Stock subject to such outstanding Incentives, including
in the Board’s discretion some or all of the shares as to which such Incentives would not otherwise be vested and exercisable;
or

 

(b)
in the case of Incentives that are either (i) settled only in shares of Common Stock, or (ii) at the election of the Participant, settled
in shares of Common Stock, paying the holder thereof an amount equal to a reasonable estimate of the difference between the net amount
per share payable in such transaction or as a result of such transaction, and the price per share of such Incentive to be paid by the
Participant (hereinafter the “Spread”), multiplied by the number of shares subject to the Incentive. In cases
where the shares constitute, or would after exercise, constitute Restricted Stock, the Company, in its discretion, may include some or
all of those shares in the calculation of the amount payable hereunder. In estimating the Spread, appropriate adjustments to give effect
to the existence of the Incentives shall be made, such as deeming the Incentives to have been exercised, with the Company receiving the
exercise price payable thereunder, and treating the shares receivable upon exercise of the Incentives as being outstanding in determining
the net amount per share. In cases where the proposed transaction consists of the acquisition of assets of the Company, the net amount
per share shall be calculated on the basis of the net amount receivable with respect to shares of Common Stock upon a distribution and
liquidation by the Company after giving effect to expenses and charges, including but not limited to taxes, payable by the Company before
such liquidation could be completed.

 

An
Award that by its terms would be fully vested or exercisable upon a Change in Control will be considered vested or exercisable for purposes
of Section 12.4(a) hereof.

 

Article
13.

LIQUIDATION OR DISSOLUTION

 

Subject
to Section 12.4 hereof, in case the Company shall, at any time while any Incentive under this Plan shall be in force and remain
unexpired, (a) sell all or substantially all of its property, or (b) dissolve, liquidate, or wind up its affairs, then each Participant
shall be entitled to receive, in lieu of each share of Common Stock of the Company which such Participant would have been entitled to
receive under the Incentive, the same kind and amount of any securities or assets as may be issuable, distributable, or payable upon
any such sale, dissolution, liquidation, or winding up with respect to each share of Common Stock of the Company. If the Company shall,
at any time prior to the expiration of any Incentive, make any partial distribution of its assets, in the nature of a partial liquidation,
whether payable in cash or in kind (but excluding the distribution of a cash dividend payable out of earned surplus and designated as
such) and an adjustment is determined by the Committee to be appropriate to prevent the dilution of the benefits or potential benefits
intended to be made available under the Plan, then the Committee shall, in such manner as it may deem equitable, make such adjustment
in accordance with the provisions of Article 11 hereof.

 

    	-18-

    	 

    

 

Article
14.

INCENTIVES IN SUBSTITUTION FOR

INCENTIVES
GRANTED BY OTHER ENTITIES

 

Incentives
may be granted under the Plan from time to time in substitution for similar instruments held by employees, independent contractors or
directors of a corporation, partnership, or limited liability company who become or are about to become Employees, Contractors or Outside
Directors of the Company or any Subsidiary as a result of a merger or consolidation of the employing corporation with the Company, the
acquisition by the Company of equity of the employing entity, or any other similar transaction pursuant to which the Company becomes
the successor employer. The terms and conditions of the substitute Incentives so granted may vary from the terms and conditions set forth
in this Plan to such extent as the Committee at the time of grant may deem appropriate to conform, in whole or in part, to the provisions
of the incentives in substitution for which they are granted.

 

Article
15.

MISCELLANEOUS
PROVISIONS

 

15.1
Investment Intent. The Company may require that
there be presented to and filed with it by any Participant under the Plan, such evidence as it may deem necessary to establish that the
Incentives granted or the shares of Common Stock to be purchased or transferred are being acquired for investment and not with a view
to their distribution.

 

15.2
No Right to Continued Employment. Neither the
Plan nor any Incentive granted under the Plan shall confer upon any Participant any right with respect to continuance of employment by
the Company or any Subsidiary.

 

15.3
Indemnification of Board and Committee.
No member of the Board or the Committee, nor any officer or Employee of the Company acting on behalf of the Board or the Committee, shall
be personally liable for any action, determination, or interpretation taken or made in good faith with respect to the Plan, and all members
of the Board and the Committee, each officer of the Company, and each Employee of the Company acting on behalf of the Board or the Committee
shall, to the extent permitted by law, be fully indemnified and protected by the Company in respect of any such action, determination,
or interpretation to the fullest extent provided by law. Except to the extent required by any unwaiveable requirement under applicable
law, no member of the Board or the Committee (and no Subsidiary of the Company) shall have any duties or liabilities, including without
limitation any fiduciary duties, to any Participant (or any Person claiming by and through any Participant) as a result of this Plan,
any Award Agreement or any Claim arising hereunder and, to the fullest extent permitted under applicable law, each Participant (as consideration
for receiving and accepting an Award Agreement) irrevocably waives and releases any right or opportunity such Participant might have
to assert (or participate or cooperate in) any Claim against any member of the Board or the Committee and any Subsidiary of the Company
arising out of this Plan.

 

15.4
Effect of the Plan. Neither the adoption of this
Plan nor any action of the Board or the Committee shall be deemed to give any person any right to be granted an Award or any other rights
except as may be evidenced by an Award Agreement, or any amendment thereto, duly authorized by the Committee and executed on behalf of
the Company, and then only to the extent and upon the terms and conditions expressly set forth therein.

 

    	-19-

    	 

    

 

15.5
Compliance with Other Laws and Regulations. Notwithstanding
anything contained herein to the contrary, the Company shall not be required to sell or issue shares of Common Stock under any Incentive
if the issuance thereof would constitute a violation by the Participant or the Company of any provisions of any law or regulation of
any governmental authority or any national securities exchange or inter-dealer quotation system or other forum in which shares of Common
Stock are quoted or traded (including without limitation Section 16 of the Exchange Act); and, as a condition of any sale or issuance
of shares of Common Stock under an Incentive, the Committee may require such agreements or undertakings, if any, as the Committee may
deem necessary or advisable to assure compliance with any such law or regulation. The Plan, the grant and exercise of Incentives hereunder,
and the obligation of the Company to sell and deliver shares of Common Stock, shall be subject to all applicable federal and state laws,
rules, and regulations and to such approvals by any government or regulatory agency as may be required.

 

15.6
Foreign Participation. To assure the viability
of Awards granted to Participants employed in foreign countries, the Committee may provide for such special terms as it may consider
necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Committee may approve such supplements
to, or amendments, restatements, or alternative versions of, this Plan as it determines is necessary or appropriate for such purposes.
Any such amendment, restatement, or alternative versions that the Committee approves for purposes of using this Plan in a foreign country
will not affect the terms of this Plan for any other country.

 

15.7
Tax Requirements. The Company or, if applicable,
any Subsidiary (for purposes of this Section 15.7, the term “Company” shall be deemed to include any
applicable Subsidiary), shall have the right to deduct from all amounts paid in cash or other form in connection with the Plan, any federal,
state, local, or other taxes required by law to be withheld in connection with an Award granted under this Plan. The Company may, in
its sole discretion, also require the Participant receiving shares of Common Stock issued under the Plan to pay the Company the amount
of any taxes that the Company is required to withhold in connection with the Participant’s income arising with respect to the Award.
Such payments shall be required to be made when requested by the Company and may be required to be made prior to the delivery of any
certificate representing shares of Common Stock. Such payment may be made by (a) the delivery of cash to the Company in an amount that
equals or exceeds (to avoid the issuance of fractional shares under (c) below) the required tax withholding obligations of the Company;
(b) if the Company, in its sole discretion, so consents in writing, the actual delivery by the exercising Participant to the Company
of shares of Common Stock that the Participant has not acquired from the Company within six (6) months prior to the date of exercise,
which shares so delivered have an aggregate Fair Market Value that equals or exceeds (to avoid the issuance of fractional shares under
(c) below) the required tax withholding payment; (c) if the Company, in its sole discretion, so consents in writing, the Company’s
withholding of a number of shares to be delivered upon the exercise of the Stock Option, which shares so withheld have an aggregate fair
market value that equals (but does not exceed) the required tax withholding payment; or (d) any combination of (a), (b), or (c). The
Company may, in its sole discretion, withhold any such taxes from any other cash remuneration otherwise paid by the Company to the Participant.
The Committee may in the Award Agreement impose any additional tax requirements or provisions that the Committee deems necessary or desirable.

 

15.8
Assignability. Incentive Stock Options may not
be transferred, assigned, pledged, hypothecated, or otherwise conveyed or encumbered other than by will or the laws of descent and distribution
and may be exercised during the lifetime of the Participant only by the Participant or the Participant’s legally authorized representative,
and each Award Agreement in respect of an Incentive Stock Option shall so provide. The designation by a Participant of a beneficiary
will not constitute a transfer of the Stock Option. The Committee may waive or modify any limitation contained in the preceding sentences
of this Section 15.8 that is not required for compliance with Section 422 of the Code.

 

    	-20-

    	 

    

 

Except
as otherwise provided herein, Awards may not be transferred, assigned, pledged, hypothecated, or otherwise conveyed or encumbered other
than by will or the laws of descent and distribution. Notwithstanding the foregoing, the Committee may, in its discretion, authorize
all or a portion of a Nonqualified Stock Option or SAR to be granted to a Participant on terms which permit transfer by such Participant
to (a) the spouse (or former spouse), children or grandchildren of the Participant (“Immediate Family Members”),
(b) a trust or trusts for the exclusive benefit of such Immediate Family Members, (c) a partnership in which the only partners are (1)
such Immediate Family Members and/or (2) entities which are controlled by the Participant and/or Immediate Family Members, (d) an entity
exempt from federal income tax pursuant to Section 501(c)(3) of the Code or any successor provision, or (e) a split interest trust or
pooled income fund described in Section 2522(c)(2) of the Code or any successor provision, provided that (x) there shall be no
consideration for any such transfer, (y) the Award Agreement pursuant to which such Nonqualified Stock Option or SAR is granted must
be approved by the Committee and must expressly provide for transferability in a manner consistent with this Section 15.8, and
(z) subsequent transfers of transferred Nonqualified Stock Options or SARs shall be prohibited except those by will or the laws of descent
and distribution.

 

Following
any transfer, any such Nonqualified Stock Option and SAR shall continue to be subject to the same terms and conditions as were applicable
immediately prior to transfer, provided that for purposes of Articles 8, 9, 11, 13 and 15 hereof the term “Participant”
shall be deemed to include the transferee. The events of Termination of Service shall continue to be applied with respect to the original
Participant, following which the Nonqualified Stock Options and SARs shall be exercisable or convertible by the transferee only to the
extent and for the periods specified in the Award Agreement. The Committee and the Company shall have no obligation to inform any transferee
of a Nonqualified Stock Option or SAR of any expiration, termination, lapse or acceleration of such Stock Option or SAR. The Company
shall have no obligation to register with any federal or state securities commission or agency any Common Stock issuable or issued under
a Nonqualified Stock Option or SAR that has been transferred by a Participant under this Section 15.8.

 

15.9
Use of Proceeds. Proceeds from the sale of shares
of Common Stock pursuant to Incentives granted under this Plan shall constitute general funds of the Company.

 

15.10
Legend. Each certificate representing shares
of Restricted Stock issued to a Participant shall bear the following legend, or a similar legend deemed by the Company to constitute
an appropriate notice of the provisions hereof (any such certificate not having such legend shall be surrendered upon demand by the Company
and so endorsed):

 

On
the face of the certificate:

 

	“Transfer
                                            of this stock is restricted in accordance with conditions printed on the reverse of this
                                            certificate.”

 

    	-21-

    	 

    

 

On
the reverse:

 

	 	“The
  shares of stock evidenced by this certificate are subject to and transferable only in accordance with that certain MyMD Pharmaceuticals,
  Inc., 2021 Equity Incentive Plan, a copy of which is on file at the principal office of the Company in Baltimore, Maryland.
  No transfer or pledge of the shares evidenced hereby may be made except in accordance with and subject to the provisions of said Plan.
  By acceptance of this certificate, any holder, transferee or pledgee hereof agrees to be bound by all of the provisions of said Plan.”

 

The
following legend shall be inserted on a certificate evidencing Common Stock issued under the Plan if the shares were not issued in a
transaction registered under the applicable federal and state securities laws:

 

	 	“Shares
  of stock represented by this certificate have been acquired by the holder for investment and not for resale, transfer or distribution,
  have been issued pursuant to exemptions from the registration requirements of applicable state and federal securities laws, and may
  not be offered for sale, sold or transferred other than pursuant to effective registration under such laws, or in transactions otherwise
  in compliance with such laws, and upon evidence satisfactory to the Company of compliance with such laws, as to which the Company may
  rely upon an opinion of counsel satisfactory to the Company.”

 

15.11
Governing Law. The Plan shall be governed by,
construed, and enforced in accordance with the laws of the State of New Jersey (excluding any conflict of laws, rule or principle of
New Jersey law that might refer the governance, construction, or interpretation of this Plan to the laws of another state). A Participant’s
sole remedy for any Claim shall be against the Company, and no Participant shall have any claim or right of any nature against any Subsidiary
of the Company or any shareholder or existing or former director, officer or Employee of the Company or any Subsidiary of the Company.
The individuals and entities described above in this Section 15.11 (other than the Company) shall be third-party beneficiaries
of this Plan for purposes of enforcing the terms of this Section 15.11.

 

A
copy of this Plan shall be kept on file in the principal office of the Company in Baltimore, Maryland.

 

***************

 

    	-22-

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this instrument to be executed as of April 16, 2021, by its Chief Financial Officer pursuant
to prior action taken by the Board.

 

	 	MyMD
    PHARMACEUTICALS, inc.
	 	 
	 	By:	/s/
    Ian Rhodes
	 	Name:	Ian
    Rhodes                       
	 	Title:	Chief
    Financial Officer

 

    	-23-Exhibit
10.4

 

FORM
OF NONQUALIFIED STOCK OPTION AGREEMENT

 

MYMD
PHARMACEUTICALS, INC.

2021
EQUITY INCENTIVE PLAN

 

1.       Grant
of Option. Pursuant to the MyMD Pharmaceuticals, Inc. 2021 Equity Incentive Plan (the “Plan”) for
Employees, Contractors, and Outside Directors of MyMD Pharmaceuticals, Inc., a New Jersey corporation (the “Company”),
the Company grants to

 

 

(the
“Participant”)

 

an
option (the “Stock Option”) to purchase a total of ___________________ (__________) full shares of Common
Stock of the Company (the “Optioned Shares”) at an “Option Price” equal to
$________ per share (being the Fair Market Value per share of the Common Stock on the Date of Grant).

 

The
“Date of Grant” of this Stock Option is _________________, 20__. The “Option Period”
shall commence on the Date of Grant and shall expire on the date immediately preceding the tenth (10th) anniversary
of the Date of Grant, unless terminated earlier in accordance with Section 4 below. The Stock Option is a Nonqualified
Stock Option that is intended to comply with the provisions governing nonqualified stock options under the final Treasury Regulations
issued on April 17, 2007, in order to exempt this Stock Option from application of Section 409A of the Code.

 

2.       Subject
to Plan. The Stock Option and its exercise are subject to the terms and conditions of the Plan, and the terms of the Plan
shall control to the extent not otherwise inconsistent with the provisions of this Nonqualified Stock Option Agreement (this “Agreement”).
The capitalized terms used herein that are defined in the Plan shall have the same meanings assigned to them in the Plan. The
Stock Option is subject to any rules promulgated pursuant to the Plan by the Board or the Committee, as applicable, and communicated
to the Participant in writing.

 

3.       Vesting;
Time of Exercise. Except as specifically provided in this Agreement and subject to certain restrictions and conditions set
forth in the Plan, the Optioned Shares shall be vested, and the Stock Option shall be exercisable as follows: [TO BE UPDATED
WITH SPECIFIC VESTING TERMS]:

 

a.       _______________________
of the total Optioned Shares shall vest and that portion of the Stock Option shall become exercisable on __________________, provided
the Participant is employed by (or, if the Participant is a Contractor or an Outside Director, is providing services to) the Company
or a Subsidiary on that date.

 

b.       _______________________
of the total Optioned Shares shall vest and that portion of the Stock Option shall become exercisable on __________________, provided
the Participant is employed by (or, if the Participant is a Contractor or an Outside Director, is providing services to) the Company
or a Subsidiary on that date.

 

c.       _______________________
of the total Optioned Shares shall vest and that portion of the Stock Option shall become exercisable on __________________, provided
the Participant is employed by (or, if the Participant is a Contractor or an Outside Director, is providing services to) the Company
or a Subsidiary on that date.

 

    	 

    	 

    

 

d.       _______________________
of the total Optioned Shares shall vest and that portion of the Stock Option shall become exercisable on __________________, provided
the Participant is employed by (or, if the Participant is a Contractor or an Outside Director, is providing services to) the Company
or a Subsidiary on that date.

 

[Notwithstanding
the foregoing, in the event that (i) a Change in Control occurs or (ii) the Participant incurs a Termination of Service due to
his death or Total and Permanent Disability, then immediately prior to the effective date of such Change in Control or qualifying
Termination of Service, the total Optioned Shares not previously vested shall thereupon immediately become vested, and this Stock
Option shall become fully exercisable, if not previously so exercisable.]

 

4.       Term;
Forfeiture.

 

a.       Except
as otherwise provided in this Agreement, to the extent the unexercised portion of the Stock Option relates to Optioned Shares
that are not vested on the date of the Participant’s Termination of Service, the Stock Option will be terminated on that
date. The unexercised portion of the Stock Option that relates to Optioned Shares which are vested on such date will terminate
at the first of the following to occur:

 

i.       5
p.m. on the date the Option Period terminates;

 

ii.       5
p.m. on the date which is twelve (12) months following the date of the Participant’s Termination of Service due to death
or Total and Permanent Disability;

 

iii.       immediately
upon the Participant’s Termination of Service by the Company for Cause (as defined herein);

 

iv.       5
p.m. on the date which is three (3) months following the date of the Participant’s Termination of Service for any reason
not otherwise specified in this Section 4.a.; or

 

v.       5
p.m. on the date the Company causes any portion of the Stock Option to be forfeited pursuant to Section 7 hereof.

 

b.       For
purposes hereof, “Cause” shall have the meaning ascribed to such term in any employment, consulting,
or other service agreement in effect by and between the Company and the Participant; provided, however, that at any time there
is no such agreement in effect, or if such agreement does not define such term, the term “Cause” shall
mean (i) a material breach or material default (including, without limitation, any material dereliction of duty) by the Participant
of any agreement between the Participant and the Company or policy of the Company, or a continuing failure by the Participant
to follow the direction of a duly authorized representative of the Company; (ii) gross negligence, willful misfeasance, or breach
of fiduciary duty to the Company by the Participant; (iii) the commission by the Participant of an act of fraud, embezzlement,
dishonesty, or any felony or other crime of moral turpitude in connection with the Participant’s duties to the Company;
(iv) conviction of the Participant of a felony or any other crime that would materially and adversely affect: (A) the business
reputation of the Company or (B) the performance of the Participant’s duties to the Company; or (v) the Participant’s
refusal to perform or intentional disregard of, the Participant’s duties and responsibilities to the Company. Any determination
of whether Cause exists shall be made by the Committee in its sole discretion.

 

    	2

    	 

    

 

5.       Who
May Exercise. Subject to the terms and conditions set forth in Sections 3 and 4 above, during the lifetime of the Participant,
the Stock Option may be exercised only by the Participant, or by the Participant’s guardian or personal or legal representative.
If the Participant’s Termination of Service is due to his death prior to the dates specified in Section 4.a. hereof,
and the Participant has not exercised the Stock Option as to the maximum number of vested Optioned Shares as set forth in Section
3 hereof as of the date of death, the following persons may exercise the exercisable portion of the Stock Option on behalf
of the Participant at any time prior to the earliest of the dates specified in Section 4.a. hereof: the personal representative
of his estate or the person who acquired the right to exercise the Stock Option by bequest or inheritance or by reason of the
death of the Participant, provided that the Stock Option shall remain subject to the other terms of this Agreement, the Plan,
and all Applicable Laws, rules, and regulations.

 

6.       No
Fractional Shares. The Stock Option may be exercised only with respect to full shares, and no fractional share of stock shall
be issued.

 

7.       Manner
of Exercise. Subject to such administrative regulations as the Committee may from time to time adopt, the Stock Option may
be exercised by the delivery of an Exercise Notice to the Committee, and the Exercise Date for the Optioned Shares being exercised
shall be at least three (3) days after giving the Exercise Notice to the Committee unless an earlier time shall have been mutually
agreed upon. On the Exercise Date, the Participant shall deliver to the Company consideration with a value equal to the total
Option Price of the shares to be purchased, payable as follows: (a) cash, check, bank draft, or money order payable to the order
of the Company; (b) if the Company, in its sole discretion, so consents in writing, Common Stock (including Restricted Stock)
owned by the Participant on the Exercise Date, valued at its Fair Market Value on the Exercise Date, and which the Participant
has not acquired from the Company within six (6) months prior to the Exercise Date; (c) if the Company, in its sole discretion,
so consents in writing, by delivery (including by FAX) to the Company or its designated agent of an executed irrevocable option
exercise form together with irrevocable instructions from the Participant to a broker or dealer, reasonably acceptable to the
Company, to sell certain of the shares of Common Stock purchased upon exercise of the Stock Option or to pledge such shares as
collateral for a loan and promptly deliver to the Company the amount of sale or loan proceeds necessary to pay such purchase price;
(d) by requesting the Company to withhold the number of shares otherwise deliverable upon exercise of the Stock Option by the
number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate Option Price at the time of exercise
(i.e., a cashless net exercise), and/or (e) in any other form of valid consideration that is acceptable to the Committee
in its sole discretion. In the event that shares of Restricted Stock are tendered as consideration for the exercise of a Stock
Option, a number of shares of Common Stock issued upon the exercise of the Stock Option equal to the number of shares of Restricted
Stock used as consideration therefor shall be subject to the same restrictions and provisions as the Restricted Stock so tendered.

 

Upon
payment of all amounts due from the Participant, the Company shall cause the Common Stock then being purchased to be electronically
registered in the Participant’s name (or the name of the person exercising the Participant’s Stock Option in the event
of the Participant’s death), promptly after the Exercise Date. The Company shall not issue certificates for Common Stock
unless the Participant (or the person exercising the Participant’s Stock Option in the event of the Participant’s
death) requests delivery of the certificates for the Common Stock in writing and in accordance with the procedures established
by the Committee. The Company shall deliver the certificates as soon as administratively practicable following the Company’s
receipt of the written request from the Participant (or the person exercising the Participant’s Stock Option in the event
of the Participant’s death) for delivery of the certificates.

 

The
obligation of the Company to register or deliver such shares of Common Stock shall, however, be subject to the condition that,
if at any time the Company shall determine in its discretion that the listing, registration, or qualification of the Stock Option
or the Common Stock upon any securities exchange or inter-dealer quotation system or under any state or federal law, or the consent
or approval of any governmental regulatory body, is necessary as a condition of, or in connection with, the Stock Option or the
issuance or purchase of shares of Common Stock thereunder, then the Stock Option may not be exercised in whole or in part unless
such listing, registration, qualification, consent, or approval shall have been effected or obtained free of any conditions not
reasonably acceptable to the Committee.

 

    	3

    	 

    

 

If
the Participant fails to pay for any of the Optioned Shares specified in such notice or fails to accept delivery thereof, that
portion of the Participant’s Stock Option and the right to purchase such Optioned Shares may be forfeited by the Participant.

 

8.       Nonassignability.
The Stock Option is not assignable or transferable by the Participant except by will or by the laws of descent and distribution.

 

9.       Rights
as Shareholder. The Participant will have no rights as a shareholder with respect to any of the Optioned Shares until the
issuance of a certificate or certificates to the Participant or the registration of such shares in the Participant’s name
for the shares of Common Stock. The Optioned Shares shall be subject to the terms and conditions of this Agreement. Except as
otherwise provided in Section 10 hereof, no adjustment shall be made for dividends or other rights for which the record
date is prior to the issuance of such certificate or certificates. The Participant, by his execution of this Agreement, agrees
to execute any documents requested by the Company in connection with the issuance of the shares of Common Stock.

 

10.       Adjustment
of Number of Optioned Shares and Related Matters. The number of shares of Common Stock covered by the Stock Option, and the
Option Prices thereof, shall be subject to adjustment in accordance with Articles 11 - 13 of the Plan.

 

11.       Nonqualified
Stock Option. The Stock Option shall not be treated as an Incentive Stock Option.

 

12.       Voting.
The Participant, as record holder of some or all of the Optioned Shares following exercise of this Stock Option, has the exclusive
right to vote, or consent with respect to, such Optioned Shares until such time as the Optioned Shares are transferred in accordance
with this Agreement; provided, however, that this Section shall not create any voting right where the holders of such Optioned
Shares otherwise have no such right.

 

13.       Specific
Performance. The parties acknowledge that remedies at law will be inadequate remedies for breach of this Agreement and consequently
agree that this Agreement shall be enforceable by specific performance. The remedy of specific performance shall be cumulative
of all of the rights and remedies at law or in equity of the parties under this Agreement.

 

14.       Participant’s
Representations. Notwithstanding any of the provisions hereof, the Participant hereby agrees that he will not exercise the
Stock Option granted hereby, and that the Company will not be obligated to issue any shares to the Participant hereunder, if the
exercise thereof or the issuance of such shares shall constitute a violation by the Participant or the Company of any provision
of any law or regulation of any governmental authority. Any determination in this connection by the Company shall be final, binding,
and conclusive. The obligations of the Company and the rights of the Participant are subject to all Applicable Laws, rules, and
regulations.

 

15.       Investment
Representation. Unless the shares of Common Stock are issued to the Participant in a transaction registered under applicable
federal and state securities laws, by his execution hereof, the Participant represents and warrants to the Company that all Common
Stock which may be purchased hereunder will be acquired by the Participant for investment purposes for his own account and not
with any intent for resale or distribution in violation of federal or state securities laws. Unless the Common Stock is issued
to him in a transaction registered under the applicable federal and state securities laws, all certificates issued with respect
to the Common Stock shall bear an appropriate restrictive investment legend and shall be held indefinitely, unless they are subsequently
registered under the applicable federal and state securities laws or the Participant obtains an opinion of counsel, in form and
substance satisfactory to the Company and its counsel, that such registration is not required.

 

    	4

    	 

    

 

16.       Legend.
The following legend shall be placed on all certificates representing Optioned Shares:

 

“The
shares evidenced by this certificate are subject to a Stock Option Agreement containing certain rights and limitations on transfer.
A copy of that agreement is on file at the principal place of business or the registered office of the Company, and a copy may
be obtained without charge upon written request to the Company at its principal place of business or its registered office.”

 

All
Optioned Shares and shares into which Optioned Shares may be converted owned by the Participant shall be subject to the terms
of this Agreement and shall be represented by a certificate or certificates bearing the foregoing legend.

 

17.       Participant’s
Acknowledgments. The Participant acknowledges that a copy of the Plan has been made available for his review by the Company
and represents that he is familiar with the terms and provisions thereof, and hereby accepts this Stock Option subject to all
the terms and provisions thereof. The Participant hereby agrees to accept as binding, conclusive, and final all decisions or interpretations
of the Committee or the Board, as appropriate, upon any questions arising under the Plan or this Agreement.

 

18.       Law
Governing. This Agreement shall be governed by, construed, and enforced in accordance with the laws of the State of New Jersey
(excluding any conflict of laws rule or principle of New Jersey law that might refer the governance, construction, or interpretation
of this Agreement to the laws of another state).

 

19.       No
Right to Continue Service or Employment. Nothing herein shall be construed to confer upon the Participant the right to continue
in the employ or to provide services to the Company or any Subsidiary, whether as an Employee, Contractor, or Outside Director,
or to interfere with or restrict in any way the right of the Company or any Subsidiary to discharge the Participant as an Employee,
Contractor, or Outside Director at any time.

 

20.       Legal
Construction. In the event that any one or more of the terms, provisions, or agreements that are contained in this Agreement
shall be held by a court of competent jurisdiction to be invalid, illegal, or unenforceable in any respect for any reason, the
invalid, illegal, or unenforceable term, provision, or agreement shall not affect any other term, provision, or agreement that
is contained in this Agreement, and this Agreement shall be construed in all respects as if the invalid, illegal, or unenforceable
term, provision, or agreement had never been contained herein.

 

21.       Covenants
and Agreements as Independent Agreements. Each of the covenants and agreements that is set forth in this Agreement shall be
construed as a covenant and agreement independent of any other provision of this Agreement. The existence of any claim or cause
of action of the Participant against the Company, whether predicated on this Agreement or otherwise, shall not constitute a defense
to the enforcement by the Company of the covenants and agreements that are set forth in this Agreement.

 

    	5

    	 

    

 

22.       Entire
Agreement. This Agreement together with the Plan supersede any and all other prior understandings and agreements, either oral
or in writing, between the parties with respect to the subject matter hereof and constitute the sole and only agreements between
the parties with respect to the said subject matter. All prior negotiations and agreements between the parties with respect to
the subject matter hereof are merged into this Agreement. Each party to this Agreement acknowledges that no representations, inducements,
promises, or agreements, orally or otherwise, have been made by any party or by anyone acting on behalf of any party, which are
not embodied in this Agreement or the Plan and that any agreement, statement, or promise that is not contained in this Agreement
or the Plan shall not be valid or binding or of any force or effect.

 

23.       Parties
Bound. The terms, provisions, and agreements that are contained in this Agreement shall apply to, be binding upon, and inure
to the benefit of the parties and their respective heirs, executors, administrators, legal representatives, and permitted successors
and assigns, subject to the limitation on assignment expressly set forth herein.

 

24.       Modification.
No change or modification of this Agreement shall be valid or binding upon the parties unless the change or modification is in
writing and signed by the parties; provided, however, that the Company may change or modify this Agreement without the Participant’s
consent or signature if the Company determines, in its sole discretion, that such change or modification is necessary for purposes
of compliance with or exemption from the requirements of Section 409A of the Code or any regulations or other guidance issued
thereunder. Notwithstanding the preceding sentence, the Company may amend the Plan to the extent permitted by the Plan.

 

25.       Headings.
The headings that are used in this Agreement are used for reference and convenience purposes only and do not constitute substantive
matters to be considered in construing the terms and provisions of this Agreement.

 

26.       Gender
and Number. Words of any gender used in this Agreement shall be held and construed to include any other gender, and words
in the singular number shall be held to include the plural, and vice versa, unless the context requires otherwise.

 

27.       Notice.
Any notice required or permitted to be delivered hereunder shall be deemed to be delivered only when actually received by the
Company or by the Participant, as the case may be, at the addresses set forth below, or at such other addresses as they have theretofore
specified by written notice delivered in accordance herewith:

 

	 	a.	Notice
    to the Company shall be addressed and delivered as follows:	 
	 	 	 	 
	 	 	MyMD
    Pharmaceuticals, Inc.	 
	 		___________________________
    	 
	 	 	___________________________	 
	 	 	Attn:_______________________	 
	 	 	Fax:________________________	 

 

	 	b.	Notice
to the Participant shall be addressed and delivered as set forth on the signature page.

 

    	6

    	 

    

 

28.
Tax Requirements. The Participant is hereby advised to consult immediately with his own tax advisor regarding the tax
consequences of this Agreement. The Company or, if applicable, any Subsidiary (for purposes of this Section 28, the
term “Company” shall be deemed to include any applicable Subsidiary), shall have the right to deduct
from all amounts paid in cash or other form in connection with the Plan and this Agreement, any federal, state, local, or other
taxes required by law to be withheld in connection with this Award. The Company may, in its sole discretion, also require the
Participant receiving shares of Common Stock issued under the Plan to pay the Company the amount of any taxes that the Company
is required to withhold in connection with the Participant’s income arising with respect to this Award. Such payments shall
be required to be made when requested by the Company and may be required to be made prior to the delivery of any certificate representing
shares of Common Stock. Such payment may be made by (a) the delivery of cash to the Company in an amount that equals or exceeds
(to avoid the issuance of fractional shares under (c) below) the required tax withholding obligations of the Company; (b) if the
Company, in its sole discretion, so consents in writing, the actual delivery by the exercising Participant to the Company of shares
of Common Stock that the Participant has not acquired from the Company within six (6) months prior to the date of exercise, which
shares so delivered have an aggregate Fair Market Value that equals or exceeds (to avoid the issuance of fractional shares under
(c) below) the required tax withholding payment; (c) if the Company, in its sole discretion, so consents in writing, the Company’s
withholding of a number of shares to be delivered upon the exercise of the Stock Option, which shares so withheld have an aggregate
Fair Market Value that equals (but does not exceed) the required tax withholding payment; or (d) any combination of (a), (b),
or (c). The Company may, in its sole discretion, withhold any such taxes from any other cash remuneration otherwise paid by the
Company to the Participant.

 

[Remainder of Page Intentionally Left Blank;

Signature Page Follows.]

 

    	7

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized officer, and the Participant, to
evidence his consent and approval of all the terms hereof, has duly executed this Agreement, as of the date specified in Section
1 hereof.

 	 	COMPANY:
	 	MYMD
    PHARMACEUTICALS, INC.
	 	
	 	By:	                                
	 	Name:	
		Title:	

	 
	 	

                                                   PARTICIPANT:

	 	 
	 	
	 	Signature
	 	 	 
	 	Name:	                    
	 	Address:
    	
	 	 	

 

    	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]